Astera Labs, Inc. Files Amendment No. 2 to S-1 Registration Statement

TL;DR

<b>Astera Labs, Inc. has filed an amendment to its S-1 registration statement, indicating its status as an emerging growth company.</b>

AI Summary

Astera Labs, Inc. (ALAB) filed a Amended IPO Registration (S-1/A) with the SEC on March 8, 2024. Astera Labs, Inc. filed an amendment (No. 2) to its S-1 registration statement on March 8, 2024. The company is incorporated in Delaware and its fiscal year ends on December 31. Its principal executive offices are located at 2901 Tasman Drive, Suite 205, Santa Clara, CA 95054. The filing indicates Astera Labs is an emerging growth company and a non-accelerated filer. The registration statement number is 333-277205.

Why It Matters

For investors and stakeholders tracking Astera Labs, Inc., this filing contains several important signals. This amendment provides updated information for potential investors as the company prepares for its initial public offering. The classification as an emerging growth company suggests potential benefits regarding regulatory disclosures and compliance requirements.

Risk Assessment

Risk Level: low — Astera Labs, Inc. shows low risk based on this filing. The filing is an amendment to a registration statement, which is a standard procedural step before an IPO and does not contain new financial performance data or significant business updates.

Analyst Insight

Monitor for the effectiveness of the registration statement and subsequent IPO pricing for investment opportunities.

Key Numbers

• 2 — Amendment Number (Amendment Number to Form S-1 Registration Statement)
• 2024-03-08 — Filing Date (Date the amendment was filed with the SEC)
• 333-277205 — Registration Number (SEC Registration Number)
• 1231 — Fiscal Year End (Company's Fiscal Year End)

Key Players & Entities

• Astera Labs, Inc. (company) — Registrant Name
• 333-277205 (regulator) — Registration Number
• Delaware (company) — State of Incorporation
• Jitendra Mohan (person) — Co-Founder and Chief Executive Officer
• Goodwin Procter LLP (company) — Legal Counsel
• Simpson Thacher & Bartlett LLP (company) — Legal Counsel

FAQ

Industry Context

Astera Labs operates in the semiconductor industry, specifically focusing on connectivity solutions for data centers.

Regulatory Implications

The filing is made under the Securities Act of 1933, which governs the registration of securities.

What Investors Should Do

1. Review the full S-1/A filing for detailed business operations and risk factors.
2. Track future SEC filings for updates on the IPO timeline and pricing.
3. Analyze the company's competitive landscape within the semiconductor market.

Year-Over-Year Comparison

This is an amendment to a previous filing, indicating procedural updates rather than a new initial filing.

Key Financial Figures

• $116M — Hyperscalers and Al Platform Providers $116MM 2023 Revenue Millions of Devices Shipp
• $17.2 billion — owing total addressable market (TAM) of $17.2 billion. Specifically, our technology and produ
• $27.4 billion — t. We believe that our TAM will grow to $27.4 billion by 2027, and we expect to address an in
• $79.9 million — of Aries in 2020. Our revenue grew from $79.9 million in 2022 to $115.8 million in 2023, driv
• $115.8 million — enue grew from $79.9 million in 2022 to $115.8 million in 2023, driven by a significant increa
• $58.3 million — annual basis. We incurred net losses of $58.3 million in 2022 and $26.3 million in 2023. As o
• $26.3 million — net losses of $58.3 million in 2022 and $26.3 million in 2023. As of December 31, 2022 and 20
• $99.1 million — 2023, we had an accumulated deficit of $99.1 million and $125.4 million, respectively. Durin
• $125.4 m — ccumulated deficit of $99.1 million and $125.4 million, respectively. During the years e
• $35.9 million — r cash used in operating activities was $35.9 million and $12.7 million, respectively. Indu
• $12.7 m — rating activities was $35.9 million and $12.7 million, respectively. Industry Backgro

Filing Documents

• d285484ds1a.htm (S-1/A) — 1946KB
• d285484dex11.htm (EX-1.1) — 298KB
• d285484dex41.htm (EX-4.1) — 17KB
• d285484dex51.htm (EX-5.1) — 7KB
• d285484dex231.htm (EX-23.1) — 1KB
• d285484dexfilingfees.htm (EX-FILING FEES) — 20KB
• g285484g00b01.jpg (GRAPHIC) — 502KB
• g285484g00b02.jpg (GRAPHIC) — 313KB
• g285484g01a01.jpg (GRAPHIC) — 133KB
• g285484g01p10.jpg (GRAPHIC) — 526KB
• g285484g02a55.jpg (GRAPHIC) — 223KB
• g285484g0306094600730.jpg (GRAPHIC) — 3KB
• g285484g03c02.jpg (GRAPHIC) — 237KB
• g285484g03c04.jpg (GRAPHIC) — 503KB
• g285484g04p11.jpg (GRAPHIC) — 195KB
• g285484g19a10.jpg (GRAPHIC) — 120KB
• g285484g19a20.jpg (GRAPHIC) — 63KB
• g285484g31x42.jpg (GRAPHIC) — 176KB
• g285484g34u90.jpg (GRAPHIC) — 110KB
• g285484g35v79.jpg (GRAPHIC) — 119KB
• g285484g38a00.jpg (GRAPHIC) — 167KB
• g285484g40p00.jpg (GRAPHIC) — 145KB
• g285484g43p01.jpg (GRAPHIC) — 107KB
• g285484g51k00.jpg (GRAPHIC) — 118KB
• g285484g51k20.jpg (GRAPHIC) — 131KB
• g285484g77f75.jpg (GRAPHIC) — 115KB
• 0001193125-24-062817.txt (&nbsp;) — 7813KB

RISK FACTORS

RISK FACTORS 17 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS 54 INDUSTRY AND MARKET DATA 56

USE OF PROCEEDS

USE OF PROCEEDS 57 DIVIDEND POLICY 58 CAPITALIZATION 59

MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS

MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 64 A LETTER FROM OUR FOUNDERS 87

BUSINESS

BUSINESS 89 MANAGEMENT 116

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 123 Page CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 133 PRINCIPAL AND SELLING STOCKHOLDERS 138

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK 141 SHARES ELIGIBLE FOR FUTURE SALE 147 MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS OF OUR COMMON STOCK 151

UNDERWRITING

UNDERWRITING 156 LEGAL MATTERS 165 EXPERTS 165 WHERE YOU CAN FIND ADDITIONAL INFORMATION 165 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS F-1 Through and including , 2024 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. You should rely only on the information contained in this prospectus, any amendment or supplement to this prospectus, or contained in any free writing prospectus filed by us with the Securities and Exchange Commission (the SEC). Neither we, the selling stockholders, nor any of the underwriters have authorized anyone to provide any information or make any representations other than those contained in this prospectus, any amendment or supplement to this prospectus, or in any free writing prospectus we have prepared. We, the selling stockholders, and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We and the selling stockholders are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions where offers and sales are permitted. The information contained in this prospectus, any amendment or supplement to this prospectus, or any free writing prospectus, is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus, any amendment or supplement to this prospectus, or any applicable free writing prospectus, as the case may be, or of any sale of our common stock. Our business, financial condition, results of operations, and prospects may have changed since that date. For investors outside of the United

View Full Filing

View this S-1/A filing on SEC EDGAR